Professional
Added to YB: 2026-07-07
Pitch date: 2026-03-31
NTRA [bullish]
Natera, Inc.
+41.19%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Natera, Inc., a diagnostics company, engages in the development and commercialization of molecular testing services worldwide.
Market Cap
$40.0B
Pitch Price
$201.00
Price Target
N/A
Dividend
N/A
EV/EBITDA
-159.25
P/E
-170.83
EV/Sales
15.66
Sector
Biotechnology
Category
growth
Show full summary:
Baron Health Care Fund New Position: Natera, Inc.
NTRA (new position): Diagnostics co, reacquired shares. Signatera MRD tests (50% of rev) are key growth driver & category leader; detect cancer cell DNA to guide therapy, monitor treatment, catch recurrence. Catalysts: new bladder/head & neck data, Japan launch driving 2027+ growth, new WGS & Latitude tests. MRD seen as $20B market.
Read full article (1 min)